Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy

Published:2020-05 Issue: Volume:150 Page:96-107
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Tu Jingyao,Tu Kun,Xu Haoran,Wang Lei,Yuan Xianglin,Qin Xianya,Kong Li,Chu Qian,Zhang Zhiping

Funder

National Natural Science Foundation of China

National Key Research and Development Plan

HUST Academic Frontier Youth Team

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference45 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J. Clin.,2018

2. Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy;Chen;Adv. Mater.,2019

3. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence;Barker;Nat. Rev. Cancer,2015

4. Hierarchical multiplexing nanodroplets for imaging-guided cancer radiotherapy via DNA damage enhancement and concomitant DNA repair prevention;Jiang;ACS Nano,2018

5. Stochastic multicellular modeling of x-ray irradiation, DNA damage induction, DNA free-end misrejoining and cell death;Forster;Sci. Rep.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade;Cancers;2024-05-14

2. Spin-orbit charge transfer from guanine and 9-methylguanine radical cations to nitric oxide radicals and the induced triplet-to-singlet intersystem crossing;The Journal of Chemical Physics;2023-08-28

3. The application and research progress of anti-angiogenesis therapy in tumor immunotherapy;Frontiers in Immunology;2023-06-02

4. Advances in the Theranostics of Oesophageal Squamous Carcinoma;Advanced Therapeutics;2023-04-16

5. Application of nano‐radiosensitizers in combination cancer therapy;Bioengineering & Translational Medicine;2023-02-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3